"Working with Novo Nordisk, we're pushing forward a new model for how life-changing GLP-1 treatments reach patientsmore affordably and at scale." Since April of 2025, Ro has worked with Novo Nordisk to help more patients access FDA-approved GLP-1 medications at the best available cash prices
This section gives quick answers to the most common questions about this insight
While these medications can be incredibly helpful, theyre not without potential downsides
The four amino acid substitutions in CJC-1295 No DAC (Ala2D-Ala, Asn8Ala, Ala15Ala, Met27Leu) provide resistance to enzymatic degradation while maintaining receptor binding affinity
Structural modifications to diol type ginsenosides form MRPs that potentiate hydroxyl (OH) radical-scavenging activity of Panax ginseng 629
TRIUMPH-1 Phase 3 confirmed results (80 weeks, 12mg dose): Why Lipid Changes Matter Non-HDL Cholesterol: This metric captures all atherogenic (plaque-forming) lipoproteins: LDL, VLDL, IDL, and Lp(a)